2. Osman AEG, Deininger MW. Chronic myeloid leukemia: Modern therapies, current challenges and future directions. Blood Rev. 2021;49:100825. 3. Rinaldi I, Winston K. Chronic myeloid leukemia, from pathophysiology to treatment-free remission: A narra...
14. Akard LP, Albitar M, Hill CE, Pinilla-Ibarz, J. The “Hit Hard and Hit Early” Approach to the Treatment of Chronic Myeloid Leukemia: Implications of the Updated National Comprehensive Cancer Network Clinical Practic...
Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities. Int J Hematol. 2023;117(1):3–15. PubMed Google Scholar Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol. 2020;95...
Treatment-free remission in Chronic Myeloid Leukemia (CML): experience of Basrah haematology centreJumaa, Ali KhazaalKhalaf, Asaad AbdulameerHasson, Hasson MahdiDawood, Qutaiba MuslimQasim, Zaynab RaadOnkologia i Radioterapia
The app includes updated treatment guidelines and community news from global events on CML. Know Your CML is created by CML Advocates Network, connecting 128 patient organisations in 93 countries on all continents. Its aim is to facilitate and support best practice sharing among patient advocates ...
14. Akard LP, Albitar M, Hill CE, Pinilla-Ibarz, J. The “Hit Hard and Hit Early” Approach to the Treatment of Chronic Myeloid Leukemia: Implications of the Updated National Comprehensive Cancer Network Clinical Practice Guidelines for Routine Practice. Clin Adv Hematol Oncol. 2013;11(7):...
Treatment of chronic myeloid leukemia has improved significantly with the introduction of tyrosine kinase inhibitors (TKIs), and treatment guidelines based on numerous clinical trials are available for chronic phase disease. However for CML in the blast
- Access to up to date CML information including guidelines, information on medicines and various support groups both for CML and for cancers in general. My CML is designed to help patients achieve improved adherence to treatment, which is particularly important in CML where there is strong eviden...
Chronic myeloid leukemia (CML) was once considered a fatal disease.With the advent of tyrosine kinase inhibitors (TKIs), however, it is now considered a cancer with which long-term survival is possible.Nevertheless, as the treatment landscape evolves, su
EP: 3.Factors Impacting CML Treatment Selection EP: 4.IRIS Trial Highlighting Role of Imatinib in CML Treatment EP: 5.OPTIC Trial Overview EP: 6.Unmet Needs Surrounding CP-CML and Ph+ ALL EP: 7.Effects of TKI Resistance and Intolerance ...